BioNTech SE
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.About BNTX
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.
CEOUgur Sahin
CEOUgur Sahin
Employees7,807
Employees7,807
HeadquartersMainz, Rheinland-Pfalz
HeadquartersMainz, Rheinland-Pfalz
Founded2008
Founded2008
Employees7,807
Employees7,807
BNTX Key Statistics
Market cap22.40B
Market cap22.40B
Price-Earnings ratio-11.37
Price-Earnings ratio-11.37
Dividend yield—
Dividend yield—
Average volume1.21M
Average volume1.21M
High today$89.80
High today$89.80
Low today$87.63
Low today$87.63
Open price$88.10
Open price$88.10
Volume1.32M
Volume1.32M
52 Week high$124.00
52 Week high$124.00
52 Week low$79.52
52 Week low$79.52
BNTX News
TipRanks 16h
BioNTech Showcases Broad Late-Stage Oncology Data and Novel Combinations at ESMO 2026BioNTech SE ( (BNTX) ) has shared an update. On October 19, 2026, BioNTech announced it will showcase new clinical data from its late-stage oncology pipeline v...
The Motley Fool 1d
Another BioNTech Cancer Vaccine Just Hit a Major Setback. Is BNTX Stock Still a Buy? - The Motley Fool...
TipRanks 6d
BioNTech Presses Ahead With BNT113 Cancer Trial After Initial Endpoint MissBioNTech SE ( (BNTX) ) has shared an announcement. On October 13, 2026, BioNTech reported first topline data from its AHEAD‑MERIT Phase 2/3 trial of investigat...
Analyst ratings
61%
of 23 ratingsBuy
60.9%
Hold
39.1%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.